Notice of first launch, interruption or termination of supply of a human drug
 DateHolderCode ▲DrugDate fromSubject
 16.12.2021Teva B.V. (TEV-NL-4)98958Citalopram-Teva 20 mg (tbl flm 100x20 mg (blis.PVC/PVDC/Al))14.1.2022O
 16.9.2021Teva B.V. (TEV-NL-4)98958Citalopram-Teva 20 mg (tbl flm 100x20 mg (blis.PVC/PVDC/Al))8.11.2021R
 16.12.2021Teva B.V. (TEV-NL-4)98954Citalopram-Teva 20 mg (tbl flm 30x20 mg (blis.PVC/PVDC/Al))14.1.2022O
 16.9.2021Teva B.V. (TEV-NL-4)98954Citalopram-Teva 20 mg (tbl flm 30x20 mg (blis.PVC/PVDC/Al))15.11.2021R
 21.11.2022Dr. Max Pharma s.r.o. (DAX)9891CDiclofenac Dr.Max 10 mg/g gél (gel 1x200 g (tuba laminátová))16.11.2022U
 6.4.2020Adamed Pharma S.A. (AFD)9886BCandezek 16 mg/10 mg (cps dur 30x16 mg/10 mg (blis.PA/Al/PVC/Al))13.4.2020R
 13.11.2019Adamed Pharma S.A. (AFD)9886BCandezek 16 mg/10 mg (cps dur 30x16 mg/10 mg (blis.PA/Al/PVC/Al))13.11.2019O
 8.8.2022Adamed Pharma S.A. (AFD)9886BCandezek 16 mg/10 mg (cps dur 30x16 mg/10 mg (blis.PA/Al/PVC/Al))30.9.2022Z
 16.9.2019Adamed Pharma S.A. (AFD)9886BCandezek 16 mg/10 mg (cps dur 30x16 mg/10 mg (blis.PA/Al/PVC/Al))1.10.2019R
 11.5.2020Adamed Pharma S.A. (AFD)9886BCandezek 16 mg/10 mg (cps dur 30x16 mg/10 mg (blis.PA/Al/PVC/Al))11.5.2020O
 11.1.2022Adamed Pharma S.A. (AFD)9878BCandezek 16 mg/5 mg (cps dur 30x16 mg/5 mg (blis.PA/Al/PVC/Al))28.1.2022Z
 22.2.2021Sandoz Pharmaceuticals d.d. (SAN-SLO-1)98732Immunoprin 50 mg (tbl flm 100x50 mg (blis.PVC/PVDC/Al))1.3.2021Z
 3.2.2022UCB Pharma S.A. (UCP)98724Xyrem 500 mg/ml perorálny roztok (sol por 1x180 ml (fľ.PE + 1odmerka -10 ml))3.2.2022Z
 2.10.2019Gedeon Richter Plc. (GDN)98630QUAMATEL 40 mg (tbl flm 56(4x14)x40 mg (blis.PVC/Al))10.12.2019Z
 23.8.2019Adamed Pharma S.A. (AFD)9862BCandezek 8 mg/5 mg (cps dur 30x8 mg/5 mg (blis.PA/Al/PVC/Al))2.9.2019R

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To